Physician profile
James David Roy
NPI 1295198216
$4,101.03
in general payments reported to CMS, 2019-2025
19 companies · $1,185 in 2025
The $1,185 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $192 · 2022: $420 · 2023: $1,159 · 2024: $1,145 · 2025: $1,185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,015 · Travel and Lodging: $1,439 · Gift: $34.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,015.23 |
| Travel and Lodging | $1,439.11 |
| Gift | $34.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,522.11 | 2023-2024 | Da Vinci Surgical System |
| Davol INC. | $1,518.75 | 2021-2025 | Phasix Mesh |
| Medtronic, INC. | $288.33 | 2022-2025 | Venaseal, Closurefast |
| Conmed Corporation | $163.32 | 2022 | |
| Urgo Medical North America, LLC | $138.12 | 2024-2025 | Urgoclean Ag, Urgok2 |
| Depuy Synthes Sales INC. | $114.52 | 2021 | |
| Baxter Healthcare | $63.46 | 2021-2022 | |
| Tela Bio, INC. | $45.54 | 2022 | |
| Novartis Pharmaceuticals Corporation | $40.85 | 2024-2025 | |
| Integra Lifesciences Corporation | $34.49 | 2022 | |
| Ethicon US, LLC | $28.60 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.02 | 2023 | Gattex |
| La Jolla Pharmaceutical Company | $19.70 | 2024 | Xacduro |
| Kerecis Limited | $19.36 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $18.59 | 2023 | Libtayo |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $16.60 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $16.57 | 2023 | Lynparza |
| Axsome Therapeutics, INC. | $16.17 | 2024 | Sunosi |
| Chiesi USA, INC. | $14.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Roy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.